iOmx Therapeutics Appoints Rüdiger Wolff as Chief Financial Officer
PRIVATEOct 01, 2026
Position
Chief Financial Officer
Company
iOmx Therapeutics AG
Rüdiger Wolff
BavariaBiotechnologyTherapeutics
Description
iOmx Therapeutics AG has announced the appointment of Rüdiger Wolff as Chief Financial Officer, effective immediately. Rüdiger joins iOmx with extensive experience in finance leadership roles within the life sciences and technology sectors.
Company Information
Company
iOmx Therapeutics AG
Location
Bavaria, Germany
About
iOmx Therapeutics is a biotechnology company developing next-generation immuno-oncology therapeutics designed to overcome resistance in solid tumors. iOmx combines tumor immunology expertise with strong biologics development capabilities to advance a pipeline of multimodal therapeutics, including multi-functional antibodies and T cell engagers.
Fundz sees it the moment iOmx Therapeutics AG changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.